BRICKELL BIOTECH INC (BBI) Stock Analyst Ratings
NASDAQ:BBI - Nasdaq - US10802T2042 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to BBI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.19. This target is 674.04% above the current price.
BBI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBI.
In the previous month the buy percentage consensus was at a similar level.
BBI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-13 | Lake Street | Downgrade | Buy -> Hold |
| 2022-03-08 | William Blair | Initiate | Outperform |
| 2022-01-18 | HC Wainwright & Co. | Initiate | Buy |